Last updated: October 5, 2023
Sponsor: Rebecka Ohm
Overall Status: Active - Recruiting
Phase
N/A
Condition
Cataplexy
Treatment
Botox injection
Neurotomy
Clinical Study ID
NCT05191719
K2018-5656
Ages 18-64 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Synkinesis following peripheral facial palsy
- Sunnybrook score <61
- Botox injections at least 3 times a year
- Have received at least 3 Botox injections
- Botox injections not satisfying treatment
- Read and signed written consent
Exclusion
Exclusion Criteria:
- Synkinesis since less than 2 years
- Contractures in facial muscles
- Other planned surgery in the face during study period
- Smoking
- Uncontrolled hypertension
- Diabetes mellitus
- Pregnancy or breast feeding
- Severe systemic disease (ASA 3-4)
Study Design
Total Participants: 73
Treatment Group(s): 2
Primary Treatment: Botox injection
Phase:
Study Start date:
February 01, 2022
Estimated Completion Date:
February 28, 2026
Study Description
Connect with a study center
Karolinska University Hospital/Karolinska Institute
Stockholm,
SwedenActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.